Kenneth B. Newman
Corporate Officer/Principal bei IONIS PHARMACEUTICALS, INC.
Aktive Positionen von Kenneth B. Newman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Karriereverlauf von Kenneth B. Newman
Ehemalige bekannte Positionen von Kenneth B. Newman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VERONA PHARMA PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2015 | 30.04.2018 |
Mesoblast, Inc.
Mesoblast, Inc. Pharmaceuticals: MajorHealth Technology Mesoblast, Inc. manufactures and distributes biopharmaceutical products. It develops cellular medicines for under-served therapeutic areas including cardiac diseases, spine orthopedic disorders, oncology and hematology diseases, and immune-mediated and inflammatory conditions. The company was founded by Michael Schuster and Silviu Itescu in 2004 and is headquartered in New York, NY. | Corporate Officer/Principal | 01.12.2013 | 01.12.2014 |
Acton Pharmaceuticals, Inc.
Acton Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acton Pharmaceuticals, Inc. developed and commercialized pharmaceutical products. The company was founded by John W. Simon and Daniel L. Kreisler in 2008 and is headquartered in Marlborough, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2010 | 01.11.2013 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | 01.01.2006 | 01.01.2009 |
FOREST LABORATORIES, INC. | Direktor/Vorstandsmitglied | - | - |
Ausbildung von Kenneth B. Newman
Duke University | Undergraduate Degree |
Carl H. Lindner College of Business | Masters Business Admin |
The University of Texas Health Science Center at Houston | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 9 |
Vereinigtes Königreich | 2 |
Operativ
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Director/Board Member | 1 |
Sektoral
Health Technology | 7 |
Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
IONIS PHARMACEUTICALS, INC. | Health Technology |
VERONA PHARMA PLC | Health Technology |
Private Unternehmen | 4 |
---|---|
Forest Laboratories, Inc.
Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY. | Health Technology |
Mesoblast, Inc.
Mesoblast, Inc. Pharmaceuticals: MajorHealth Technology Mesoblast, Inc. manufactures and distributes biopharmaceutical products. It develops cellular medicines for under-served therapeutic areas including cardiac diseases, spine orthopedic disorders, oncology and hematology diseases, and immune-mediated and inflammatory conditions. The company was founded by Michael Schuster and Silviu Itescu in 2004 and is headquartered in New York, NY. | Health Technology |
Acton Pharmaceuticals, Inc.
Acton Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acton Pharmaceuticals, Inc. developed and commercialized pharmaceutical products. The company was founded by John W. Simon and Daniel L. Kreisler in 2008 and is headquartered in Marlborough, MA. | Health Technology |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |
- Börse
- Insiders
- Kenneth B. Newman
- Erfahrung